Systolic Target Assessment Tool (STAT)

Portable, non-invasive method of delivering continuous, accurate, and timely data on a patient’s systolic blood pressure.


Project at a Glance

Product Type:
Device

Project Start Date:
July 1, 2017

Principal Investigators:
Kevin Ward, MD
Hakam Tiba, MD, MS

Solution Sheet:
Download Solution Sheet (PDF)

Intellectual Property:
Invention Disclosure # 5907
Patent Issued # US10271740B2

Funding History: $187,685 in non-dilutive funding
• 2017 $73,975 2017 Massey Grand Challenge
• 2019 $113,710 2019 Massey Grand Challenge • Substantial additional departmental, school and center based support


Overview

Image credit: pexels.com

Image credit: pexels.com

Weil Institute researchers are developing a portable, non-invasive method of delivering continuous, accurate, and timely data on a patient’s systolic blood pressure. The Systolic Target Assessment Tool (STAT) combines pulse oximeter and blood pressure cuff data with a programmable algorithm to near-continuously monitor SBP.

Significant Need

Systolic Blood Pressure (SBP) is the pressure of the blood in the arteries when the heart pumps. Blood pressure that fails to meet certain critical thresholds is deadly, with hypotension and hypoxia associated with higher mortality among out-of-hospital patients. It is crucial that caregivers, regardless of treatment location, have an accurate read on a patient’s SBP. Unfortunately, while SBP target values exist for resuscitation and maintenance in the early care of traumatic brain injury and polytrauma, our current methods for continuous SBP monitoring are limited, often restricted to hospital settings, and provide data that is neither accurate nor timely.

Competitive Advantage

STAT’s portability allows for innumerable applications in emergency departments, all ground/air ambulances, and out in the field (active combat, multi-casualty incidents, etc.) Continuous SBP monitoring with STAT can expedite prevention, detection, and treatment of blood pressure complications like hypotension and hypoxia. If the pressure falls below a clinician-selected goal, the device sounds audible and visual alarms.

  • Continuous Monitoring

  • Less Invasive

  • Quick Results

  • Numerous Applications


Funding Organization(s)


Publications

None at this time